REGEN FACTOR
ReGen Factor AIMS TO BECOME THE GLOBAL LEADER IN THE RECOMBIANT HUMAN BASIC FIBROBLAST GROWTH FACTOR INDUSTRY AS AN INNOVATIVE TREATMENT FOR MAJOR HEALTH CONDITIONS AND DISEASES.

— WHAT WE DO
FIBROBLAST GROWTH FACTORS
FIBROBLAST GROWTH FACTORS REGULATE A BROAD SPECTRUM OF BIOLOGICAL FUNCTIONS INCLUDING CELLULAR PROLIFERATION, SURVIVAL, MIGRATION AND DIFFERENTIATION

— HOW IT WORKS
PEPFACTOR
USING OUR BIO-IDENTICAL GROWTH FACTORS WE HAVE DESIGNED PEPFACTOR SKIN AND SCALP TO ENHANCE THE ANTI-AGING APPEARANCE OF SKIN AND REJUVENATE HAIR GROWTH

— WHY WE DO IT
FUTURE PRODUCTS
WE ARE DEVELOPING NEW PRODUCTS THAT UTILIZE OUR GROWTH FACTORS INCLUDING DIABETIC ULCER WOUND HEALING, METABOLISM BOOSTING TREATMENT FOR TYPE 2 DIABETES & SKIN CANCER PREVENTION AND TREATMENT

— WHAT'S NEXT
Previous slide
Next slide

WHO ARE WE?

  • We are an Australian propriety company limited by shares.

  • We discover, develop and commercialise novel fibroblast growth factors for applications in hair regrow for humans, and wound healing pharmaceuticals for human and veterinary markets.

  • Our lead product, bFGF is a large molecule for the treatment of androgenetic alopecia in humans with applications for wound healing across various species.

  • The simultaneous development of products for both the vet and human markets enables validation of technology and reduces risks of drugs for human development, while generating early revenues.

Latest Company Announcement

New Product for Diabetic Ulcers

An Innovative Approach to Wound Healing with Bio-Identical Basic Fibroblast Growth Factor (rh-bFGF)

PepFactor for Androgenetic Alopecia

Pre-Clinical Trials to commence in New Jersey…

PepFactor Skin - The solution ...

Pre-Clinical Trials data promising

PepFactor to Treat Diabetic Ulcers

Bio-Identical benefits of BFGF

London Calling

ReGen Factor Quarterly Update – Q3 2024

ReGen Factor Shareholder Update – H2 2024

Our PepFactor Science | ReGen Factor

OUR SCIENCE

ReGen Factor has developed first to market technology to produce bio-identical and cost effective Fibroblast growth factors (FGFs) which regulate a broad spectrum of biological functions, including cellular proliferation, survival, migration and differentiation. The ReGen Factor scientific team have discovered a way to produce bFGF at less than 10% of the current production cost.

PIPELINE & CLINICAL TRIALS

ReGen Factor aims to establish PepFactor Scalp as the world leading treatment for Adrogenous genetic Alopecia (AGA) in both men and women.

ReGen Factor has completed their initial cosmetic trials on the efficacy and safety of PepFactor Scalp treatments for the treatment of androgenic alopecia with no adverse reactions reported.

MARKET SHARE

The global alopecia market is estimated at USD $2.6 billion in 2019 and is expected to reach USD 14.2 billion by 2028.

The market is expected to expand at a CAGR of 8.1% from 2021 to 2028 with an increasing approval for laser-based therapy to treat driving growth.


REGEN FACTOR

Australia-based Progressive R&D skin biology company

ReGen Factor is an Australia-based progressive R&D skin biology company with a global reach. ReGen Factor has developed first-to-market technology to produce bio-identical and cost-effective Fibroblast growth factors (FGFs), which regulate a broad spectrum of biological functions, including cellular proliferation, survival, migration, and differentiation.

We are making a global impact in the cosmetic, cosmeceutical, and pharmaceutical industries with a firm commitment to technology and innovation and our expertise in bio-identical, cost-effective fibroblast growth factors.

PEPFACTOR

PepFactor is an advanced skin and scalp rejuvenation treatment formulated by doctors and scientists which is designed to stimulate the body’s own synthesis of natural fibroblast in the skin to drastically increase collagen and elastin, delivering never seen before results.

PepFactor utilizes the world’s first natural and bio-identical protein to stimulate the body’s skin and scalp for unsurpassed rejuvenation.

PepFactor offers clients an alternative to surgery for glowing, healthy-looking, natural skin rejuvenation and thicker, healthier-looking hair for both men and women.

OUR SCIENCE (Tech and Stats)

ReGen Factor uses our proprietary production method to create the world’s first authentic bio-identical fibroblast growth factor for use in our products.

With an amino acid sequence identical to our natural Basic Fibroblast Growth Factor (bFGF) structure, PepFactor is 98% pure and encourages the body’s natural stimulation of biological functions.

ReGen Factor uses its novel production technology to ensure its growth factors are affordable and have high efficacy, purity, and stability for the best results at an affordable price.

PepFactor | ReGen Factor

WHY INVEST

ReGen Factor is an Australia-based progressive R&D skin biology company with a global reach. ReGen Factor has developed first-to-market technology to produce bio-identical and cost-effective Fibroblast growth factors (FGFs), which regulate a broad spectrum of biological functions, including cellular proliferation, survival, migration, and differentiation.

We are making a global impact in the cosmetic, cosmeceutical, and pharmaceutical industries with a firm commitment to technology and innovation and our expertise in bio-identical, cost-effective fibroblast growth factors.

DO YOU HAVE ANY QUESTIONS?

We help our patients feel their best, look their best and rediscover theiryouth. Contact us today to get started!

PepFactor GROWTH PIPELINES

PepFactor SALES PIPELINE

PEPFACTOR COSMETIC SALES

Maximise sales of PepFactor as a cosmetic product in the scalp and skin markets: sales currently US$90k per month

PEPFACTOR DISTRIBUTION

Sales and distrIbution are rapidly expanding.

TRADEMARK REGISTRATIONS

Trademarks have neen submitted

DEVELOPMENT PATENT

Patent for ReGen Factors uniguee development method have been processed

CE MARK

CE Mark to be submitted for registration of PepFactor for sale in the European Union and the UK

PepFactor FDA APPROVAL PIPELINE

FDA CONSULTANTS

FOA consultants have been appointed to navigate the FDA approval process

PRIMARY INVESTIGATOR

A primary investigator for the phase 1 trial has been appointed

TRIAL DESIGN AND PLANNING

Trial design and planning is underway

PRE-IND MEETING

Preparations are being made for a Pre-IND meeting to be held H2 2021

PHASE 1 TRIAL

Phase1 Clinical Trial to Commence 2022

SCHEDULE YOUR
FREE CONSULTATION NOW!

RECENT NEWS

Quarterly Update

Welcome to ReGen Factor’s latest quarterly update. Since our last update in May 2022, we have made significant strides towards achieving our goals. This update

Read More »

Get In Touch!

Fill out the form below, and we will be in touch shortly.
Contact Information
Preferred Date and Time Selection